HORIZON
PATH-FOR-YOUNG
Personalized Adjuvant Treatment for HR+/HER2- breast cancer FOR YOUNG patients
- Programme
- Horizon Europe
- Started
- Ends
- Duration
- 84 months
- Total cost
- Not stated
- EU contribution
- EUR 9,498,604
- Participants
- 17 from 12 countries
- Topic
- HORIZON_HORIZON-HLTH-2024-DISEASE-03-08-two-stage
- Grant agreement
- 101156800
Coordinated by Unicancer (FRFrance).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Unicancer | FRFrance | Coordinator | EUR 4,447,320 | known name (0.95) |
| Grupo Argentino de Investigacion Clinica en Oncologia Asociacion Civil | ARArgentina | Participant | EUR 83,344 | PIC (1.00) |
| ANZ Breast Cancer Trials Group Ltd | AUAustralia | Associated partner | EUR 0 | PIC (1.00) |
| Association Hospitaliere de Bruxelles-Centre Hospitalier Universitaire Jules Bordet | BEBelgium | Participant | EUR 353,125 | PIC (1.00) |
| Instituto D'Or de Pesquisa e Ensino | BRBrazil | Associated partner | EUR 0 | PIC (1.00) |
| Latin American Cooperative Oncology Group | BRBrazil | Associated partner | EUR 0 | PIC (1.00) |
| Gr Espanol de Estudio y Tratamientode Intensific. y Otras Estrateg.experiment. en Tumores Solidos - Grupo Solti | ESSpain | Participant | EUR 242,906 | PIC (1.00) |
| assistance publique hopitaux de paris | FRFrance | Participant | EUR 129,375 | name shared with others (0.80) |
| Institut Gustave Roussy | FRFrance | Participant | EUR 434,500 | PIC (1.00) |
| Resilience | FRFrance | Participant | EUR 76,250 | PIC (1.00) |
| University of Warwick | GBUnited Kingdom | Participant | EUR 1,373,275 | known name (0.95) |
| Cancer Trials Ireland Company Limited By Guarantee | IEIreland | Participant | EUR 158,400 | PIC (1.00) |
| Clinical Research Technology SRL | ITItaly | Participant | EUR 188,688 | PIC (1.00) |
| Europa Donna the European Breast Cancer Coalition | ITItaly | Participant | EUR 182,950 | PIC (1.00) |
| Stichting Eupati Foundation | NLNetherlands | Participant | EUR 183,925 | PIC (1.00) |
| Grupo de Estudios Clinicos Oncologico Peruano Gecoperu | PEPeru | Participant | EUR 158,575 | PIC (1.00) |
| Dana-Farber Cancer Institute Inc | USUnited States | Participant | EUR 10,000 | PIC (1.00) |
Changes of the consortium
First seen on with 17 participants from 12 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.